STAT
JUNE 11, 2025
Europe’s comparatively cautious approach to food additives is the envy of health secretary Robert F. Kennedy Jr. and the Make America Healthy Again movement. A Texas bill now before Gov. Greg Abbott aims to help close the gap by slapping warning labels on foods that contain any of 44 additives and dyes. Abbott has not said whether he intends to sign Senate Bill 25 into law.
NY Times
JUNE 11, 2025
Skip to content Skip to site index Today’s Paper Opinion | It’s Code Red for Vaccines [link] Share full article 205 205 Advertisement SKIP ADVERTISEMENT You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load. Opinion Supported by SKIP ADVERTISEMENT Guest Essay It’s Code Red for Vaccines June 11, 2025, 5:03 a.m.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 11, 2025
In December 2023, a groundbreaking announcement grabbed headlines : After years of anticipation, the Food and Drug Administration approved the first gene therapies for treating sickle cell disease, offering hope of eliminating life-altering symptoms. News at the time also featured the treatment’s prohibitive cost — between $2 and $3 million per person.
Drug Patent Watch
JUNE 11, 2025
"Patent Puzzle: How to Outmaneuver Big Pharma's Monopolies As the cost of prescription medications continues to skyrocket, patients and healthcare providers are fighting back against Big Pharma's stranglehold on the market. But with billions of dollars in research and development at stake, the pharmaceutical industry will stop at nothing to protect its intellectual property.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
JUNE 11, 2025
For more than a half-century, the Centers for Disease Control and Prevention has relied on outside experts to guide the agency’s recommendations on how vaccines should be used to prevent the spread of infectious disease. That task will now fall to a panel that includes several individuals who’ve either been openly critical of vaccines or who have scant infectious disease expertise.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
JUNE 11, 2025
The new agency at the center of health secretary Robert F. Kennedy Jr.’s agenda is hitting its first hurdle: Congress. The administration’s sweeping reorganization plan for the Department of Health and Human Services would shrink the National Institutes of Health and slash a litany of disease prevention programs while making the Administration for a Healthy America a new crown jewel of the agency, focused on chronic disease.
Pharmacy Joe
JUNE 11, 2025
In this episode, I’ll discuss things a pharmacist should keep in mind when managing a patient with a caustic ingestion. Episode 1034: Pharmacy Considerations When Managing Caustic Ingestion Subscribe on iTunes , Android , or Stitcher According to an article in Intensive Care Medicine, caustic or corrosive ingestion in adult patients is a rare but potentially life-threatening condition with a mortality of 10% among intensive care unit (ICU) patients.
Express Pharma
JUNE 11, 2025
Scientific discovery has always relied on good, clean data. Bad data leads to ir- reproducible outcomes, prob- lematic solutions, and, ultimately, the need to revisit and acquire better data. Now that AI-driven predictive models are becoming more commonplace in early drug discovery workflows, the importance of data that is ac- curate and consistent across en- tire research workflows has never been greater.
World Pharma News
JUNE 11, 2025
We have all heard of antibodies - proteins produced by our bodies to bind to viruses or bacteria, marking them for elimination by the immune system. But not all of us are familiar with aptamers: short segments of DNA or RNA that are designed to bind, like antibodies, to specific targets. Synthetic and inexpensive to produce, aptamers are attractive alternatives to antibodies for biomedical diagnostics and therapeutics.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
RX Note
JUNE 11, 2025
Introduction The patient care process is a fundamental series of actions that guide the activities of health professionals. In 2014, the Joint Commission for Pharmacy Practitioners (JCPP) - representing 11 national pharmacy organizations - endorsed a framework for providing clinically oriented patient care services called the Pharmacist's Patient Care Process.
PharmaShots
JUNE 11, 2025
Shots: The US FDA has approved the IND application of NVC-001 to treat LMNA-related dilated cardiomyopathy (LMNA DCM), enabling a P-I/II trial to start in early 2026 Preclinical studies showed that NVC-001 significantly improved survival and cardiac function. They planned a P-I/II trial, a 52-week, open-label, multicenter ascending-dose study to assess the safety, tolerability, and preliminary efficacy of one-time IV NVC-001 in adults with LMNA-DCM NVC-001 is an AAV-based gene therapy for LMNA-D
BioPharma Dive
JUNE 11, 2025
The company is paying $350 million upfront, and potentially over $1.3 billion overall, for a radiopharmaceutical for prostate cancer that works differently than Novartis’ Pluvicto.
PharmaShots
JUNE 11, 2025
Shots: Philochem and RayzeBio (BMS) entered into a development and commercialization agreement under which Philochem granted RayzeBio exclusive worldwide rights to develop, manufacture, and commercialize its radiopharmaceutical agent OncoACP3 for prostate cancer Under the agreement, Philochem will receive $350M up front and is eligible for up to $1B in development, regulatory, and commercial milestones, plus mid-single to low double-digit royalties for both therapeutic and diagnostic agents of
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmafile
JUNE 11, 2025
BioDuro, a contract research, development and manufacturing organisation, has announced a strategic partnership with small molecule design specialist Silicogenix (SGX) to accelerate polypharmacology and non-traditional drug development. The collaboration will combine BioDuro’s drug discovery capabilities with SGX’s design frameworks to streamline the development of complex therapeutics.
The Pharmacist
JUNE 11, 2025
Respiratory lead pharmacist Nazir Hussain offers his top practical tips on how to conduct effective asthma reviews and optimise asthma medication in line with updated asthma guidelines The joint asthma guidelines from NICE, the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN) represent a significant opportunity to rethink and improve asthma management […] The post Ten tips for optimising asthma management at review appeared first on The Pharmacist.
Med Ed 101
JUNE 11, 2025
Trimethoprim-sulfamethoxazole (Bactrim) is a commonly prescribed antibiotic for urinary tract and other infections. However, it’s also associated with several clinically significant drug interactions that can lead to serious patient harm if overlooked. Here are my top five Bactrim drug interactions you need to watch for—especially in the elderly and patients on multiple medications.
Pharma Marketing Network
JUNE 11, 2025
The pharmaceutical industry has long been revered for its scientific breakthroughs, drug innovation, and commitment to patient health. Yet when it comes to modern marketing strategy, some argue the industry is trailing behind. While retail, finance, and tech sectors have embraced real-time analytics, AI personalization, and omnichannel messaging, pharma marketing still clings to outdated models.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
BioPharma Dive
JUNE 11, 2025
The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to help overcome the packaging constraints of current genetic medicines.
PharmaShots
JUNE 11, 2025
Shots: The US FDA has approved Ibtrozi (taletrectinib) for treating locally advanced or metastatic ROS1+ NSCLC Approval was based on the P-II [ TRUST-I (China) & TRUST-II (global)] studies assessing Ibtrozi monotx. in 173 & 164 pts with ROS1+ NSCLC, respectively TRUST-I showed a cORR of 90% in TKI-naïve pts, with longest DoR of 46.9mos. & ongoing (mFU: 40mos.) while TRUST-II showed 85% cORR with DoR of 30.4mos. & ongoing, as of Oct 2024 (mFU: 19mos.); mDoR was not yet reached for
Pharmafile
JUNE 11, 2025
Sanofi and Regeneron have announced results from the collaborative phase 4 DISCOVER study, presented at the Revolutionizing Atopic Dermatitis Conference, Nashville, US, on 7 June, highlighting the impact of Dupixent (dupilumab) in patients with moderate-to-severe atopic dermatitis (AD) and skin of colour. The open-label trial enrolled 120 patients with Fitzpatrick skin types IV–VI, including Black, […] The post Dupixent improves symptoms in patients with skin of colour, study shows appeare
Pharma Marketing Network
JUNE 11, 2025
Pharmaceutical marketing has always been a dynamic force within the healthcare ecosystem. In 2025, the pace of change is faster than ever, driven by innovations in digital technology, new regulatory landscapes, and shifting expectations among healthcare providers and patients alike. So what exactly is pharmaceutical marketing today, and how is it adapting to meet tomorrow’s challenges?
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharma Times
JUNE 11, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Bimekizumab shows lasting efficacy at EULAR 2025 by John Pinching | 11th Jun 2025 | News Three-year data highlights inflammation control in psoriatic arthritis UCB has announced new three-year data from phase 3 trials and their open-label extensions investigating BIMZELX (bimekizumab) in psoriatic arthri
Pharmaceutical Business Review
JUNE 11, 2025
MRT-8102 is a NEK7-directed molecular glue degrader being developed to treat inflammatory diseases driven by the NLRP3 inflammasome and IL-1β. Monte Rosa Therapeutics CEO Markus Warmuth said: “The IND clearance of MRT-8102 is another important milestone in our quest to broadly establish MGDs as a modality in immunology and inflammatory (I&I) indications.
Pharmaceutical Commerce
JUNE 11, 2025
In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven insights can support PBMs and healthcare leaders in negotiating fairer drug prices?
The Pharmacist
JUNE 11, 2025
Two community pharmacy multiples are among the top 20 employers that have been called out by the government for paying their staff below minimum wage. In the latest His Majesty’s Revenue and Customs (HMRC) list, more than 500 companies have failed to pay the national living and national minimum wage. Of all those named by […] The post Two pharmacy multiples among top 20 employers failing to pay minimum wage appeared first on The Pharmacist.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JUNE 11, 2025
Retail pharmacies are undergoing a meaningful transformation into accessible, community-based health care hubs by expanding clinical services, embracing value-based care, and addressing gaps in access, technology, and reimbursement.
pharmaphorum
JUNE 11, 2025
Meet Dyasonic, a Marvel-inspired superhero with type 1 diabetes whose mission is to help patients feel "seen, understood, and represented"
The Pharmacist
JUNE 11, 2025
A collective £200,000 is owed in unpaid locum fees by just one pharmacy business, according to the Pharmacists’ Defence Association (PDA). The union said the amount of debts owed to locum staff recovered by the PDA has ‘increased dramatically’ over the last few years. The PDA says it recovers more than £100,000, every year, but […] The post PDA recovers ‘record’ levels of unpaid locum fees appeared first on The Pharmacist.
Expert insights. Personalized for you.
290 
Let's personalize your content